1. Abelev, G.I., 1971, Alpha-fetoprotein in ontogenesis and its association with maligant tumors. Adv. Caner Res.14:295–358.
2. Arbuthnot, P., Bralet, M.-P., Thomassin, H., Danan, J.-L., Brechot, C., and Ferry, N., 1995, Hepatoma cell-specific expression of a retrovirally transferred gene is achieved by α-fetoprotein but not insulin like growth factor II regulatory sequences, Hepatology22:1788–1796.
3. Bois-Joyeux, B., and Danan, J.-L., 1994, Members of the CAAT/enhancer-binding protein, hepatocyte nuclear factor-1 and nuclear factor-1 families can differentially modulate the activities of the rat α-fetoprotein promoter and enhancer, Biochem. J.301:49–55.
4. Bui, L.A., Butterfield, L.H., Kim, J.Y., Ribas, A., Seu, P., Lau, R., Glaspy, J.A., McBride, W.H., and Economou, J.S., 1997, In vivo therapy of hepatocellular carcinoma with a tumor specific adenoviral vector expressing interleukin-2, Hum. Gene Ther.8:2173–2181.
5. Camper, S.A., and Tilghman, S.M., 1989, Postnatal repression of the α-fetoprotein gene is enhancer independent, Genes Devel.3:537–546.